ARTICLE SUMMARY:
It’s worth paying attention to the diabetes space, no matter your medtech focus.
The medical device arena is nothing if not diverse. But there are important lessons to be learned and models to be adapted from one sector to the next, including in regulatory and reimbursement strategy.
